![Blair Jackson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Blair Jackson
Direttore operativo presso
ALKERMES PLC
Patrimonio netto: 10 M $ in data 31/05/2026
Profilo
Blair C. Jackson è nel consiglio di amministrazione di Alkermes Pharma Ireland Ltd. e direttore operativo e vicepresidente esecutivo di Alkermes Plc. Nella sua carriera passata il signor Jackson è stato vicepresidente dello sviluppo aziendale per Alkermes, Inc. Il signor Jackson ha conseguito una laurea presso l'Università di Calgary, un MBA e una laurea presso l'Università di Alberta e una laurea presso il Massachusetts Institute of Technology.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 13/03/2026 | 241.308 ( 0,14% ) | 10 M $ | 31/05/2026 |
Posizioni attive di Blair Jackson
| Società | Posizione | Inizio |
|---|---|---|
| ALKERMES PLC | Direttore operativo | 11/01/2021 |
Alkermes Pharma Ireland Ltd.
 Alkermes Pharma Ireland Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures oral dosage products | Direttore/Membro del Consiglio | - |
Synchronicity Pharma, Inc.
 Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Discovers, develops and commercializes novel therapeutics | Direttore/Membro del Consiglio | 01/10/2018 |
Rodin Therapeutics, Inc.
 Rodin Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disorders | Presidente | - |
Precedenti posizioni note di Blair Jackson
| Società | Posizione | Fine |
|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Corporate Officer/Principal | 01/01/2021 |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Direttore/Membro del Consiglio | 01/01/2015 |
Formazione di Blair Jackson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
57
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Calgary
 University of Calgary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synchronicity Pharma, Inc.
Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Discovers, develops and commercializes novel therapeutics | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
Alkermes Plc
 Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Alkermes Pharma Ireland Ltd.
Alkermes Pharma Ireland Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures oral dosage products | Health Technology |
Rodin Therapeutics, Inc.
Rodin Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disorders | Health Technology |
